ArticleSkeletal muscle2026
Humidity impacts volatile anesthetic and heat responses of malignant hyperthermia susceptible mice.
Article in Skeletal muscle, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundMalignant Hyperthermia (MH) is characterized by life-threatening whole-body hyperthermic reactions triggered by volatile anesthetics in susceptible individuals. MH susceptibility (MHS) and exertional heat stroke (EHS) are linked to mutations in the type I ryanodine receptor (RYR1). However, the discordance between the estimated prevalence of RYR1 MHS mutations in the general population (1:625-1,075) and the occurrence of MH episodes during anesthesia (1:100,000) suggests additional factors beyond genetics.
methodsUsing an established MHS mouse model (Y524S or YS mice), 10-12-week-old WT and YS mice were exercised on a treadmill (20° incline, 15 m/min, 60 min) and/or exposed to heat (15 min at 37℃) or 2% isoflurane either in a low or high humid environment. A second cohort of 10-12-week-old WT and YS mice were exposed to 2% isoflurane under a low or high humid environment. Vehicle or dantrolene (4 mg/kg) was administered during isoflurane exposure once the rectal temperature reached 39℃. Rectal temperature was continuously monitored under all conditions. In addition, historical humidity and temperature data were collected from dates on which MHS individuals either experienced or did not experience a defined MH episode.
resultsIn young, but not older, YS male mice, survival rates significantly decreased during heat challenge (HR Dry/Humid = 0.1621, P = 0.018) and isoflurane exposure in a humid environment (HR Dry/Humid = 0.2273, P = 0.035). Dantrolene improved survival (HR DMSO/Dantrolene ranging from 4.959 to 8.667 in all conditions) and slowed the rate of core temperature increase in young YS mice regardless of humidity. Humidity was similarly associated with increased MH occurrence (AUC = 0.8104, P = 0.0026) in male MHS patients.
conclusionsAbsolute humidity was associated with worsened outcomes during heat and isoflurane exposure in male MHS mice and an increase in MH occurrence in male MHS patients. These results support maintaining humidity levels within operating suites at lower levels of current guidelines, especially where dantrolene is not available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.